Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2004;10(2):75–85. doi: 10.1080/13550280490280292

Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development

Sonia Navas-Martín 1, Susan R Weiss 1,✉
PMCID: PMC7095027  PMID: 15204926

Abstract

A novel coronavirus has been recently identified as the causative agent of the severe acute respiratory syndrome (SARS) outbreak that has accounted for more than 8000 infected people worldwide. This review will discuss current knowledge on coronavirus replication, pathogenesis, evolution, and vaccine strategies, as well as the most recent findings on SARS coronavirus.

Keywords: coronavirus mutation, replication, SARS, vaccine

References

  1. Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Fleming JO, Baker SC. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology. 1995;209:337–346. doi: 10.1006/viro.1995.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anton IM, Sune C, Meloen RH, Borras-Cuesta F, Enjuanes L. A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology. 1995;212:746–751. doi: 10.1006/viro.1995.1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashraf H. WHO declares Beijing to be free of SARS. Lancet. 2003;361:2212–2212. doi: 10.1016/S0140-6736(03)13790-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baric RS, Nelson GW, Fleming JO, Deans RJ, Keck JG, Casteel N, Stohlman SA. Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol. 1988;62:4280–4287. doi: 10.1128/jvi.62.11.4280-4287.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baric RS, Sullivan E, Hensley L, Yount B, Chen W. Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J Virol. 1999;73:638–649. doi: 10.1128/jvi.73.1.638-649.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, Hammarstrom S, Holmes KV, Karlsson A, Kuroki M, Lin SH, Lucka L, Najjar SM, Neumaier M, Obrink B, Shively JE, Skubitz KM, Stanners CP, Thomas P, Thompson JA, Virji M, von Kleist S, Wagener C, Watt S, Zimmermann W. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res. 1999;252:243–249. doi: 10.1006/excr.1999.4610. [DOI] [PubMed] [Google Scholar]
  7. Bergmann CC, Dimacali E, Stohl S, Marten N, Lai MM, Stohlman SA. Viral evolution and CTL epitope stability during JHMV infection in the central nervous system. Adv Exp Med Biol. 1998;440:751–757. doi: 10.1007/978-1-4615-5331-1_97. [DOI] [PubMed] [Google Scholar]
  8. Bergmann CC, Marten NW, Hinton DR, Parra B, Stohlman SA. CD8T cell mediated immunity to neurotropic MHV infection. Adv Exp Med Biol. 2001;494:299–308. doi: 10.1007/978-1-4615-1325-4_46. [DOI] [PubMed] [Google Scholar]
  9. Bonavia A, Arbour N, Yong VW, Talbot PJ. Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J Virol. 1997;71:800–806. doi: 10.1128/jvi.71.1.800-806.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM, Detsky AS. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
  11. Boots AM, Kusters JG, van Noort JM, Zwaagstra KA, Rijke E, van der Zeijst BA, Hensen EJ. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology. 1991;74:8–13. [PMC free article] [PubMed] [Google Scholar]
  12. Brian DA, Spaan WJM. Recombination and coronavirus defective interfering RNAs. Semin Virol. 1997;8:101–111. doi: 10.1006/smvy.1997.0109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Buchmeier MJ, Lane TE. Viral-induced neurodegenerative disease. Curr Opin Microbiol. 1999;2:398–402. doi: 10.1016/S1369-5274(99)80070-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cavanagh D, Mawditt K, Welchman Dde B, Britton P, Gough RE. Coronaviruses from pheasants (Phasianus colchicus) are genetically closely related to coronaviruses of domestic fowl (infectious bronchitis virus) and turkeys. Avian Pathol. 2002;31:81–93. doi: 10.1080/03079450120106651. [DOI] [PubMed] [Google Scholar]
  15. Chen DS, Asanaka M, Chen FS, Shively JE, Lai MM. Human carcinoembryonic antigen and biliary glycoprotein can serve as mouse hepatitis virus receptors. J Virol. 1997;71:1688–1691. doi: 10.1128/jvi.71.2.1688-1691.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chen DS, Asanaka M, Yokomori K, Wang F, Hwang SB, Li HP, Lai MM. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A. 1995;92:12095–12099. doi: 10.1073/pnas.92.26.12095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chen W, Baric RS. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol. 1996;70:3947–3960. doi: 10.1128/jvi.70.6.3947-3960.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chua MM, MacNamara K, San Mateo L, Shen H, Weiss SR. Effects of an epitope specific CD8+ T cell response on murine coronavirus CNS disease: protection from virus replication and antigen spread and selection of epitope escape mutants. J Virol. 2004;78:1150–1159. doi: 10.1128/JVI.78.3.1150-1159.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet. 2003;362:293–294. doi: 10.1016/S0140-6736(03)13973-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. de Haan CA, Masters PS, Shen X, Weiss S, Rottier PJ. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuatingin the natural host. Virology. 2002;296:177–189. doi: 10.1006/viro.2002.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. de Haan CA, van Genne L, Stoop JN, Volders H, Rottier PJ. Coronaviruses as vectors: position dependence of foreign gene expression. J Virol. 2003;77:11312–11323. doi: 10.1128/JVI.77.21.11312-11323.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Haan CA, Volders H, Koetzner CA, Masters PS, Rottier PJ. Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol. 2002;76:12491–12502. doi: 10.1128/JVI.76.24.12491-12502.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Domingo E, Biefricher C, Holland JJ, Eigen M. Quasispecies and RNA virus evolution: principles and consequences. Austin, TX: Landes Bioscience; 2001. [Google Scholar]
  24. Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol. 1997;51:151–178. doi: 10.1146/annurev.micro.51.1.151. [DOI] [PubMed] [Google Scholar]
  25. Domingo E, Menendez-Arias L, Holland JJ. RNA virus fitness. Rev Med Virol. 1997;7:87–96. doi: 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  26. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM, Anderson RM. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761–1766. doi: 10.1016/S0140-6736(03)13410-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Drake JW. A constant rate of spontaneous mutation in DNA-based microbes. Proc Natl Acad Sci U S A. 1991;88:7160–7164. doi: 10.1073/pnas.88.16.7160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. doi: 10.1056/NEJMoa030747. [DOI] [PubMed] [Google Scholar]
  29. Drosten C, Preiser W, Gunther S, Schmitz H, Doerr HW. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med. 2003;9:325–327. doi: 10.1016/S1471-4914(03)00133-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Dveksler GS, Dieffenbach CW, Cardellichio CB, McCuaig K, Pensiero MN, Jiang GS, Beauchemin N, Holmes KV. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J Virol. 1993;67:1–8. doi: 10.1128/jvi.67.1.1-8.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dveksler GS, Gagneten SE, Scanga CA, Cardellichio CB, Holmes KV. Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection. J Virol. 1996;70:4142–4145. doi: 10.1128/jvi.70.6.4142-4145.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Enjuanes LBD, Cavanagh D, Holmes K, Lai MMC, Laude H, Masters P, Rottier P, Sidell SG, Spaan WJM, Taguchi F, Talbot P. Coronaviridae. In: van Regenmortel MHVFC, Bishop DHL, Carsten EB, Estes MK, Lemon SM, McGeoch DJ, Maniloff J, Mayo MA, Pringle CR, Wickner RB, editors. Virus taxonomy classification and nomemclature of viruses. San Diego: Academic Press; 2000. pp. 835–849. [Google Scholar]
  33. Escors D, Camafeita E, Ortego J, Laude H, Enjuanes L. Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol. 2001;75:12228–12240. doi: 10.1128/JVI.75.24.12228-12240.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Everard ML, Swarbrick A, Rigby AS, Milner AD. The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity. Respir Med. 2001;95:275–280. doi: 10.1053/rmed.2001.1033. [DOI] [PubMed] [Google Scholar]
  35. Farsang A, Ros C, Renstrom LH, Baule C, Soos T, Belak S. Molecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain. Avian Pathol. 2002;31:229–236. doi: 10.1080/03079450220136530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Fischer F, Peng D, Hingley ST, Weiss SR, Masters PS. The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J Virol. 1997;71:996–1003. doi: 10.1128/jvi.71.2.996-1003.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6:601–608. doi: 10.3201/eid0606.000608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Fleck F. WHO says SARS outbreak is over, but fight should go on. BMJ. 2003;327:70–70. doi: 10.1136/bmj.327.7406.70-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Fleming JO, Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Baker SC. Mutations associated with viral sequences isolated from mice persistently infected with MHV-JHM. Adv Exp Med Biol. 1995;380:591–595. doi: 10.1007/978-1-4615-1899-0_94. [DOI] [PubMed] [Google Scholar]
  40. Fleming JO, Houtman JJ, Alaca H, Hinze HC, McKenzie D, Aiken J, Bleasdale T, Baker S. Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4. Adv Exp Med Biol. 1993;342:327–332. doi: 10.1007/978-1-4615-2996-5_50. [DOI] [PubMed] [Google Scholar]
  41. Gallagher TM. Murine coronavirus spike glycoprotein. Receptor binding and membrane fusion activities. Adv Exp Med Biol. 2001;494:183–192. [PubMed] [Google Scholar]
  42. Glansbeek HL, Haagmans BL, te Lintelo EG, Egberink HF, Duquesne V, Aubert A, Horzinek MC, Rottier PJ. Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. J Gen Virol. 2002;83:1–10. doi: 10.1099/0022-1317-83-1-1. [DOI] [PubMed] [Google Scholar]
  43. Godfraind C, Langreth SG, Cardellichio CB, Knobler R, Coutelier JP, Dubois-Dalcq M, Holmes KV. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab Invest. 1995;73:615–627. [PubMed] [Google Scholar]
  44. Gombold JL, Hingley ST, Weiss SR. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J Virol. 1993;67:4504–4512. doi: 10.1128/jvi.67.8.4504-4512.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Gonzalez JM, Gomez-Puertas P, Cavanagh D, Gorbalenya AE, Enjuanes L. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol. 2003;148:2207–2235. doi: 10.1007/s00705-003-0162-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS, Poon LL. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–278. doi: 10.1126/science.1087139. [DOI] [PubMed] [Google Scholar]
  47. Haring J, Perlman S. Mouse hepatitis virus. Curr Opin Microbiol. 2001;4:462–466. doi: 10.1016/S1369-5274(00)00236-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ, de Groot RJ. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol. 1998;72:4508–4514. doi: 10.1128/jvi.72.5.4508-4514.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Hingley ST, Gombold JL, Lavi E, Weiss SR. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology. 1994;200:1–10. doi: 10.1006/viro.1994.1156. [DOI] [PubMed] [Google Scholar]
  50. Hingley ST, Gombold JL, Lavi E, Weiss SR. Hepatitis mutants of mouse hepatitis virus strain A59. Adv Exp Med Biol. 1995;380:577–582. doi: 10.1007/978-1-4615-1899-0_92. [DOI] [PubMed] [Google Scholar]
  51. Holland J, Domingo E. Origin and evolution of viruses. Virus Genes. 1998;16:13–21. doi: 10.1023/A:1007989407305. [DOI] [PubMed] [Google Scholar]
  52. Holmes KV. Coronaviridae: the viruses and their replication. In: Fields BN, editor. Fields virology. Philadelphia: Lippincott-Raven; 1996. pp. 1075–1103. [Google Scholar]
  53. Holmes KV. SARS-associated coronavirus. NEngl J Med. 2003;348:1948–51. doi: 10.1056/NEJMp030078. [DOI] [PubMed] [Google Scholar]
  54. Huelsenbeck JP, Ronquist F, Nielsen R, Bollback JP. Bayesian inference of phylogeny and its impact on evolutionary biology. Science. 2001;294:2310–2314. doi: 10.1126/science.1065889. [DOI] [PubMed] [Google Scholar]
  55. Hung EC, Chim SS, Chan PK, Tong YK, Ng EK, Chiu RW, Leung CB, Sung JJ, Tam JS, Lo YM. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49:2108–2109. doi: 10.1373/clinchem.2003.025437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Jia W, Karaca K, Parrish CR, Naqi SA. A novel variant of avian infectious bronchitis virus resulting from recombination among three different strains. Arch Virol. 1995;140:259–271. doi: 10.1007/BF01309861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Jonassen CM, Jonassen TO, Grinde B. A common RNA motif in the 3′ end of the genomes of astroviruses, avian infectious bronchitis virus and an equine rhinovirus. J Gen Virol. 1998;79:715–718. doi: 10.1099/0022-1317-79-4-715. [DOI] [PubMed] [Google Scholar]
  58. Keck JG, Matsushima GK, Makino S, Fleming JO, Vannier DM, Stohlman SA, Lai MM. In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol. 1988;62:1810–1813. doi: 10.1128/jvi.62.5.1810-1813.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Keck JG, Soe LH, Makino S, Stohlman SA, Lai MM. RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol. 1988;62:1989–1998. doi: 10.1128/jvi.62.6.1989-1998.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Koo M, Bendahmane M, Lettieri GA, Paoletti AD, Lane TE, Fitchen JH, Buchmeier MJ, Beachy RN. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci USA. 1999;96:7774–7779. doi: 10.1073/pnas.96.14.7774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Koolen MJ, Borst MA, Horzinek MC, Spaan WJ. Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J Virol. 1990;64:6270–6273. doi: 10.1128/jvi.64.12.6270-6273.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Koren G, King S, Knowles S, Phillips E. Ribavirin in the treatment of SARS: a new trick for an old drug? Chin Med Assoc J. 2003;168:1289–1292. [PMC free article] [PubMed] [Google Scholar]
  63. Kottier SA, Cavanagh D, Britton P. Experimental evidence of recombination in coronavirus infectious bronchitis virus. Virology. 1995;213:569–580. doi: 10.1006/viro.1995.0029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kottier SA, Cavanagh D, Britton P. First experimental evidence of recombination in infectious bronchitis virus. Recombination in IBV. Adv Exp Med Biol. 1995;380:551–556. doi: 10.1007/978-1-4615-1899-0_88. [DOI] [PubMed] [Google Scholar]
  65. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. [DOI] [PubMed] [Google Scholar]
  66. Kunz J, Krause D, Kremer M, Dermietzel R. The 140-kDa protein of blood-brain barrier-associated pericytes is identical to aminopeptidase N. J Neurochem. 1994;62:2375–2386. doi: 10.1046/j.1471-4159.1994.62062375.x. [DOI] [PubMed] [Google Scholar]
  67. La Monica N, Yokomori K, Lai MM. Coronavirus mRNA synthesis: identification of novel transcription initiation signals which are differentially regulated by different leader sequences. Virology. 1992;188:402–407. doi: 10.1016/0042-6822(92)90774-J. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003;199:496–508. doi: 10.1002/path.1291. [DOI] [PubMed] [Google Scholar]
  69. Lai MM. RNA recombination in animal and plant viruses. Microbiol Rev. 1992;56:61–79. doi: 10.1128/mr.56.1.61-79.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S, Sung JJ. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. doi: 10.1056/NEJMoa030685. [DOI] [PubMed] [Google Scholar]
  71. Leparc-Goffart I, Hingley ST, Chua MM, Jiang X, Lavi E, Weiss SR. Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology. 1997;239:1–10. doi: 10.1006/viro.1997.8877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, Yuen KY, Sung JJ. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125:1011–1017. doi: 10.1016/j.gastro.2003.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Li L, Wo J, Shao J, Zhu H, Wu N, Li M, Yao H, Hu M, Dennin RH. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J Clin Virol. 2003;28:239–244. doi: 10.1016/S1386-6532(03)00195-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi: 10.1038/nature02145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA. Antibody prevents virus reactivation within the central nervous system. J Immunol. 1999;162:7358–7368. [PubMed] [Google Scholar]
  76. Lipman MM, Cotler SJ. Antiviral therapy for hepatitis C. Curr Treat Options Gastroenterology. 2003;6:445–453. doi: 10.1007/s11938-003-0046-1. [DOI] [PubMed] [Google Scholar]
  77. Liu C, Kokuho T, Kubota T, Watanabe S, Inumaru S, Yokomizo Y, Onodera T. DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus. Virus Res. 2001;80:75–82. doi: 10.1016/S0168-1702(01)00333-1. [DOI] [PubMed] [Google Scholar]
  78. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest. 1989;83:1299–1307. doi: 10.1172/JCI114015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Luytjes W, Bredenbeek PJ, Noten AF, Horzinek MC, Spaan WJ. Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology. 1988;166:415–422. doi: 10.1016/0042-6822(88)90512-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC, Krajden M, Petric M, Skowronski DM, Upton C, Roper RL. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. doi: 10.1126/science.1085953. [DOI] [PubMed] [Google Scholar]
  81. Marten NW, Stohlman SA, Atkinson RD, Hinton DR, Fleming JO, Bergmann CC. Contributions of CD8+ T cells and viral spread to demyelinating disease. J Immunol. 2000;164:4080–4088. doi: 10.4049/jimmunol.164.8.4080. [DOI] [PubMed] [Google Scholar]
  82. Marten NW, Stohlman SA, Bergmann CC. MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol. 2001;14:1–18. doi: 10.1089/08828240151061329. [DOI] [PubMed] [Google Scholar]
  83. Martin J, Navas S, Quiroga JA, Pardo M, Carreno V. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine. 1998;10:635–644. doi: 10.1006/cyto.1997.0333. [DOI] [PubMed] [Google Scholar]
  84. Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Peiris JS, Lim W, Osterhaus AD. Virology: SARS virus infection of cats and ferrets. Nature. 2003;425:915–915. doi: 10.1038/425915a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Matthews AE, Weiss SR, Shlomchik MJ, Hannum LG, Gombold JL, Paterson Y. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J Immunol. 2001;167:5254–5263. doi: 10.4049/jimmunol.167.9.5254. [DOI] [PubMed] [Google Scholar]
  86. Myint SH. Human coronaviruses—a brief review. Rev Med Virol. 1994;4:35–46. doi: 10.1002/rmv.1980040108. [DOI] [Google Scholar]
  87. Navas-Martín S, Weiss SR (2003). SARS: lessons learned from other coronaviruses. J Viral Immunol In press. [DOI] [PubMed]
  88. Nedellec P, Dveksler GS, Daniels E, Turbide C, Chow B, Basile AA, Holmes KV, Beauchemin N. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J Virol. 1994;68:4525–4537. doi: 10.1128/jvi.68.7.4525-4537.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773–1778. doi: 10.1016/S0140-6736(03)13413-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Nie QH, Luo XD, Zhang JZ, Su Q. Current status of severe acute respiratory syndrome in China. World J Gastroenterol. 2003;9:1635–1645. doi: 10.3748/wjg.v9.i8.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Olsen CW, Corapi WV, Jacobson RH, Simkins RA, Saif LJ, Scott FW. Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity. J Gen Virol. 1993;74:745–749. doi: 10.1099/0022-1317-74-4-745. [DOI] [PubMed] [Google Scholar]
  92. Ortego J, Sola I, Almazan F, Ceriani JE, Riquelme C, Balasch M, Plana J, Enjuanes L. Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology. 2003;308:13–22. doi: 10.1016/S0042-6822(02)00096-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Parry J. WHO investigates China’s fall in SARS cases. BMJ. 2003;326:1285–1285. doi: 10.1136/bmj.326.7402.1285-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. doi: 10.1016/S0140-6736(03)13412-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Perlman S, Pewe L. Role of CTL mutants in demyelination induced by mouse hepatitis virus, strain JHM. Adv Exp Med Biol. 1998;440:515–519. doi: 10.1007/978-1-4615-5331-1_66. [DOI] [PubMed] [Google Scholar]
  97. Perlman S, Wu GF. Selection of and evasion from cytotoxic T cell responses in the central nervous system. Adv Virus Res. 2001;56:219–242. doi: 10.1016/S0065-3527(01)56029-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Pewe L, Heard SB, Bergmann C, Dailey MO, Perlman S. Selection of CTL escape mutants in mice infected with a neurotropic coronavirus: quantitative estimate of TCR diversity in the infected central nervous system. J Immunol. 1999;163:6106–6113. [PubMed] [Google Scholar]
  99. Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity. 1996;5:253–262. doi: 10.1016/S1074-7613(00)80320-9. [DOI] [PubMed] [Google Scholar]
  100. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995–2005. doi: 10.1056/NEJMoa030634. [DOI] [PubMed] [Google Scholar]
  101. Pratelli A, Tinelli A, Decaro N, Cirone F, Elia G, Roperto S, Tempesta M, Buonavoglia C. Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol. 2003;26:151–155. [PubMed] [Google Scholar]
  102. Prentice E, Denison MR. The cell biology of coronavirus infection. Adv Exp Med Biol. 2001;494:609–614. doi: 10.1007/978-1-4615-1325-4_90. [DOI] [PubMed] [Google Scholar]
  103. Reilley B, Van Herp M, Sermand D, Dentico N. SARS and Carlo Urbani. N Engl J Med. 2003;348:1951–1952. doi: 10.1056/NEJMp030080. [DOI] [PubMed] [Google Scholar]
  104. Rest JS, Mindell DP. SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting. Infect Genet Evol. 2003;3:219–225. doi: 10.1016/j.meegid.2003.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Robitaille J, Izzi L, Daniels E, Zelus B, Holmes KV, Beauchemin N. Comparison of expression patterns and cell adhesion properties of the mouse biliary glycoproteins Bbgp1 and Bbgp2. Eur J Biochem. 1999;264:534–544. doi: 10.1046/j.1432-1327.1999.00660.x. [DOI] [PubMed] [Google Scholar]
  106. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399. doi: 10.1126/science.1085952. [DOI] [PubMed] [Google Scholar]
  107. Rowe CL, Baker SC, Nathan MJ, Fleming JO. Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J Virol. 1997;71:2959–2969. doi: 10.1128/jvi.71.4.2959-2969.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Rowe CL, Baker SC, Nathan MJ, Sgro JY, Palmenberg AC, Fleming JO. Quasispecies development by high frequency RNA recombination during MHV persistence. Adv Exp Med Biol. 1998;440:759–765. doi: 10.1007/978-1-4615-5331-1_98. [DOI] [PubMed] [Google Scholar]
  109. Rowe CL, Fleming JO, Nathan MJ, Sgro JY, Palmenberg AC, Baker SC. Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure. J Virol. 1997;71:6183–6190. doi: 10.1128/jvi.71.8.6183-6190.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Schickli JH, Wentworth DE, Zelus BD, Holmes KV, Sawicki SG. Selection in persistently infected murine cells of an MHV-A59 variant with extended host range. Adv Exp Med Biol. 1998;440:735–741. doi: 10.1007/978-1-4615-5331-1_95. [DOI] [PubMed] [Google Scholar]
  111. Schickli JH, Zelus BD, Wentworth DE, Sawicki SG, Holmes KV. The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range. J Virol. 1997;71:9499–9507. doi: 10.1128/jvi.71.12.9499-9507.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Siddell SG. The Coronaviridae. New York: Plenum Press; 1995. [Google Scholar]
  113. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 2003;331:991–1004. doi: 10.1016/S0022-2836(03)00865-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Steinhauer DA, Domingo E, Holland JJ. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene. 1992;122:281–288. doi: 10.1016/0378-1119(92)90216-C. [DOI] [PubMed] [Google Scholar]
  115. Takamura K, Matsumoto Y, Shimizu Y. field study of bovine coronavirus vaccine enriched with hemagglutinating antigen for winter dysentery in diary cows. Can J Vet Res. 2002;66:278–281. [PMC free article] [PubMed] [Google Scholar]
  116. Talbot PJ. Implication of viruses in multiple sclerosis. Med Sci. 1995;11:837–843. [Google Scholar]
  117. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, Sung RY, Buckley TA, Tam JS, Cheng AF. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol. 2001;63:242–246. doi: 10.1002/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  118. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 2003;9:1064–1069. doi: 10.3201/eid0909.030362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. van der Veen RC. Immunogenicity of JHM virus proteins: characterization of a CD4+ T cell epitope on nucleocapsid protein which induces different T-helper cell subsets. Virology. 1996;225:339–346. doi: 10.1006/viro.1996.0608. [DOI] [PubMed] [Google Scholar]
  120. Vennema H, Godeke GJ, Rossen JW, Voorhout WF, Horzinek MC, Opstelten DJ, Rottier PJ. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 1996;15:2020–2028. doi: 10.1002/j.1460-2075.1996.tb00553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Wang X, Khan MI. Molecular characterization of an infectious bronchitis virus strain isolated from an outbreak in vaccinated layers. Avian Dis. 2000;44:1000–1006. doi: 10.2307/1593079. [DOI] [PubMed] [Google Scholar]
  122. Wang X, Schnitzlein WM, Tripathy DN, Girshick T, Khan MI. Construction and immunogenicity studies of recombinant fowl poxvirus containing the S1 gene of Massachusetts 41 strain of infectious bronchitis virus. Avian Dis. 2002;46:831–838. doi: 10.1637/0005-2086(2002)046[0831:CAISOR]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  123. Weiss R, Scott FW. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorragic fever. Comp Immunol Microbiol Infect Dis. 1981;4:175–189. doi: 10.1016/0147-9571(81)90003-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Wentworth DE, Holmes KV. Addition of a single glycosylation site to hAPN blocks human coronavirus-229E receptor activity. Adv Exp Med Biol. 2001;494:199–204. doi: 10.1007/978-1-4615-1325-4_32. [DOI] [PubMed] [Google Scholar]
  125. Wentworth DE, Holmes KV. Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J Virol. 2001;75:9741–9752. doi: 10.1128/JVI.75.20.9741-9752.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. World Health Organization (WHO) (2003). Severe acute respiratory syndrome (SARS): multi-country outbreak.
  127. Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus induced demyelination. J Immunol. 2000;165:2278–2286. doi: 10.4049/jimmunol.165.4.2278. [DOI] [PubMed] [Google Scholar]
  128. Wu GF, Dandekar AA, Pewe L, Perlman S. The role of CD4 and CD8 T cells in MHV-JHM-induced demyelination. Adv Exp Med Biol. 2001;494:341–347. doi: 10.1007/978-1-4615-1325-4_51. [DOI] [PubMed] [Google Scholar]
  129. Wu GF, Pewe L, Perlman S. Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase. J Virol. 2000;74:7683–7686. doi: 10.1128/JVI.74.16.7683-7686.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Wu HY, Guy JS, Yoo D, Vlasak R, Urbach E, Brian DA. Common RNA replication signals exist among group 2 coronaviruses: evidence for in vivo recombination between animal and human coronavirus molecules. Virology. 2003;315:174–183. doi: 10.1016/S0042-6822(03)00511-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J. Molecular model of SARS coronavirus polymerase: implications for biochemical functions sand drug design. Nucleic Acids Res. 2003;31:7117–7130. doi: 10.1093/nar/gkg916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Xue S, Jaszewski A, Perlman S. Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus. Virology. 1995;208:173–179. doi: 10.1006/viro.1995.1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Xue S, Perlman S. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology. 1997;238:68–78. doi: 10.1006/viro.1997.8819. [DOI] [PubMed] [Google Scholar]
  134. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357:420–422. doi: 10.1038/357420a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A. 2003;100:12995–13000. doi: 10.1073/pnas.1735582100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Yu L, Liu W, Schnitzlein WM, Tripathy DN, Kwang J. Avian Dis. 2001;45:340–348. doi: 10.2307/1592973. [DOI] [PubMed] [Google Scholar]
  137. Yu X, Bi W, Weiss SR, Leibowitz JL. Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology. 1994;202:1018–1023. doi: 10.1006/viro.1994.1430. [DOI] [PubMed] [Google Scholar]
  138. Zhong NS, Zheng BJ, Li YM, Poon, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ, Xu J, Li DX, Yuen KY, Peiris, Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet. 2003;362:1353–1358. doi: 10.1016/S0140-6736(03)14630-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurovirology are provided here courtesy of Nature Publishing Group

RESOURCES